Lipopolysaccharide-induced expression of NAD(P)H:quinone oxidoreductase 1 and heme oxygenase-1 protects against excessive inflammatory responses in human monocytes

Journal of Immunology

Volumn 181, Issue 10, 2008, Pages 6730-6737

  Rushworth, Stuart A ^a,b   MacEwan, David J ^a   O'Connell, Maria A ^a,b  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEME OXYGENASE 1; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); TRANSCRIPTION FACTOR NRF2; HMOX1 PROTEIN, HUMAN; NFE2L2 PROTEIN, HUMAN; NQO1 PROTEIN, HUMAN; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DETOXIFICATION; GENE EXPRESSION; GENE FUNCTION; GENE SILENCING; HUMAN; HUMAN CELL; INFLAMMATION; INNATE IMMUNITY; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; BIOSYNTHESIS; CELL LINE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPSIS;

CELL LINE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE SILENCING; HEME OXYGENASE-1; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; LIPOPOLYSACCHARIDES; MONOCYTES; NAD(P)H DEHYDROGENASE (QUINONE); NF-E2-RELATED FACTOR 2; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 58149181985     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.10.6730     Document Type: Article

References (45)

1. Sands, K. E., D. W. Bates, P. N. Lanken, P. S. Graman, P. L. Hibberd, K. L. Kahn, J. Parsonnet, R. Panzer, E. J. Orav, D. R. Snydman, et al. 1997. Epidemiology of sepsis syndrome in 8 academic medical centers. J. Am. Med. Assoc. 278: 234-240. (Pubitemid 27339591)
2. Alberti, C., C. Brun-Buisson, H. Burchardi, C. Martin, S. Goodman, A. Artigas, A. Sicignano, M. Palazzo, R. Moreno, R. Boulme, et al. 2002. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med. 28: 108-121. (Pubitemid 34293822)
3. Vincent, J. L., D. J. Bihari, P. M. Suter, H. A. Bruining, J. White, M. H. Nicolaschanoin, M. Wolff, R. C. Spencer, and M. Hemmer. 1995. The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) Study: EPIC International Advisory Committee. J. Am. Med. Assoc. 274: 639-644.
4. Martin, G. S., D. M. Mannino, S. Eaton, and M. Moss. 2003. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348: 1546-1554. (Pubitemid 36437931)
5. Rietschel, E. T., and H. Brade. 1992. Bacterial endotoxins. Sci. Am. 267: 54-61.
6. Cohen, J. 2002. The immunopathogenesis of sepsis. Nature 420: 885-891.
7. Sweet, M. J., and D. A. Hume. 1996. Endotoxin signal transduction in macrophages. J. Leukocyte Biol. 59: 280-286.
8. Ishii, T., K. Itoh, S. Takahashi, H. Sato, T. Yanagawa, Y. Katoh, S. Bannai, and M. Yamamoto. 2000. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J. Biol. Chem. 275: 16023-16029. (Pubitemid 30366908)
9. Lee, J. M., M. J. Calkins, K. M. Chan, Y. W. Kan, and J. A. Johnson. 2003. Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. J. Biol. Chem. 278: 12029-12038.
10. Jeong, W. S., M. Jun, and A. N. Kong. 2006. Nrf2: a potential molecular target for cancer chemoprevention by natural compounds. Antioxid. Redox Signal. 8: 99-106. (Pubitemid 43324535)
11. Chen, X. L., S. E. Varner, A. S. Rao, J. Y. Grey, S. Thomas, C. K. Cook, M. A. Wasserman, R. M. Medford, A. K. Jaiswal, and C. Kunsch. 2003. Laminar flow induction of antioxidant response element-mediated genes in endothelial cells: a novel anti-inflammatory mechanism. J. Biol. Chem. 278: 703-711.
12. Thimmulappa, R. K., H. Lee, T. Rangasamy, S. P. Reddy, M. Yamamoto, T. W. Kensler, and S. Biswal. 2006. Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J. Clin. Invest. 116: 984-995.
13. Thimmulappa, R. K., R. J. Fuchs, D. Malhotra, C. Scollick, K. Traore, J. H. Bream, M. A. Trush, K. T. Liby, M. B. Sporn, T. W. Kensler, and S. Biswali. 2007. Preclinical evaluation of targeting the Nrf2 pathway by triterpenoids (CDDO-Im and CDDO-Me) for protection from LPS-induced inflammatory response and reactive oxygen species in human peripheral blood mononuclear cells and neutrophils. Antioxid. Redox Signal. 9: 1963-1970.
14. Guo, R. F., and P. A. Ward. 2007. Role of oxidants in lung injury during sepsis. Antioxid. Redox Signal. 9: 1991-2002. (Pubitemid 47622351)
15. Guha, M., and N. Mackman. 2001. LPS induction of gene expression in human monocytes. Cell. Signal. 13: 85-94. (Pubitemid 32222977)
16. Rushworth, S. A., X. L. Chen, N. Mackman, R. M. Ogborne, and M. A. O'Connell. 2005. Lipopolysaccharide-induced heme oxygenase-1 expression in human monocytic cells is mediated via Nrf2 and protein kinase C. J. Immunol. 175: 4408-4415.
17. Chen, Y. H., S. F. Yet, and M. A. Perrella. 2003. Role of heme oxygenase-1 in the regulation of blood pressure and cardiac function. Exp. Biol. Med. 228: 447-453. (Pubitemid 37203658)
18. Poss, K. D., and S. Tonegawa. 1997. Reduced stress defense in heme oxygenase 1-deficient cells. Proc. Natl. Acad. Sci. USA 94: 10925-10930.
19. Thimmulappa, R. K., K. H. Mai, S. Srisuma, T. W. Kensler, M. Yamamato, and S. Biswal. 2002. Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res. 62: 5196-5203.
20. Otterbein, L. E., and A. M. K. Choi. 2000. Heme oxygenase: colors of defense against cellular stress. Am. J. Physiol. 279: L1029-L1037.
21. Ishii, Y., K. Itoh, Y. Morishima, T. Kimura, T. Kiwamoto, T. Ilzuka, A. E. Hegab, T. Hosoya, A. Nomura, T. Sakamoto, et al. 2005. Transcription factor Nrf2 plays a pivotal role in protection against elastase-induced pulmonary inflammation and emphysema. J. Immunol. 175: 6968-6975. (Pubitemid 41598943)
22. Bloom, D. A., and A. K Jaiswal. 2003. Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response element-mediated NAD(P)H: quinone oxidoreductase-1 gene expression. J. Biol. Chem. 278: 44675-44682.
23. Huang, H. C., T. Nguyen, and C. B. Pickett. 2002. Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J. Biol. Chem. 277: 42769-42774.
24. McMahon, M., K. Itoh, M. Yamamoto, and J. D. Hayes. 2003. Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J. Biol. Chem. 278: 21592-21600. (Pubitemid 36792558)
25. Zhang, D. D., S. C. Lo, J. V. Cross, D. J. Templeton, and M Hannink. 2004. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol. Cell. Biol. 24: 10941-10953.
26. Kimura, M., T. Yamamoto, J. Zhang, K. Itoh, M. Kyo, T. Kamiya, H. Aburatani, F. Katsuoka, H. Kurokawa, T. Tanaka, et al. 2007. Molecular basis distinguishing the DNA binding profile of Nrf2-Maf heterodimer from that of Maf homodimer. J. Biol. Chem. 282: 33681-33690. (Pubitemid 350159507)
27. Itoh, K., T. Chiba, S. Takahashi, T. Ishii, K. Igarashi, Y. Katoh, T. Oyake, N. Hayashi, K. Satoh, I. Hatayama, et al. 1997. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236: 313-322. (Pubitemid 27373291)
28. Boyum, A. 1968. Isolation of mononuclear cells and granulocytes from human blood: isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand. J. Clin. Lab. Invest. Suppl. 21: 77-89.
29. O'Connell, M. A., B. L. Bennett, F. Mercurio, A. M. Manning, and N. Mackman. 1998. Role of IKK1 and IKK2 in lipopolysaccharide signaling in human monocytic cells. J. Biol. Chem. 273: 30410-30414.
30. Zhou, Z., M. C. Connell, and D. Mac Ewan. 2007. TNFR1-induced NF-κB, but not ERK, p38 MAPK or JNK activation, mediates TNF-induced ICAM-1 and VCAM-1 expression on endothelial cells. Cell. Signal. 19: 1238-1248. (Pubitemid 46561561)
31. Cordle, S. R., R. Donald, M. A. Read, and J. Hawiger. 1993. Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-Rel and related NF-κB proteins in human monocytic THP-1 cells. J. Biol. Chem. 268: 11803-11810. (Pubitemid 23168134)
32. Chi, L., Y. Ke, C. Luo, D. Gozal, and R. Liu. 2007. Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo. Neuroscience 144: 991-1003. (Pubitemid 46013990)
33. Ryan, K. A., M. F. Smith, Jr., M. K. Sanders, and P. B. Ernst. 2004. Reactive oxygen and nitrogen species differentially regulate Toll-like receptor 4-mediated activation of NF-κB and interleukin-8 expression. Infect. Immun. 72: 2123-2130.
34. Rushworth, S. A., and M. A. O'Connell. 2004. Haem oxygenase-1 in inflammation. Biochem. Soc. Trans. 32: 1093-1094.
35. Koike, Y., T. Hisada, M. Utsugi, T. Ishizuka, Y. Shimizu, A. Ono, Y. Murata, J. Hamuro, M. Mori, and K. Dobashi. 2007. Glutathione redox regulates airway hyperresponsiveness and airway inflammation in mice. Am. J. Respir. Cell Mol. Biol. 37: 322-329. (Pubitemid 350067611)
36. He, X. Q., M. G. Chen, G. X. Lin, and Q. Ma. 2006. Arsenic induces NAD(P)H-quinone oxidoreductase I by disrupting the Nrf2 x Keap1 x Cul3 complex and recruiting Nrf2 x Maf to the antioxidant response element enhancer. J. Biol. Chem. 281: 23620-23631.
37. Yao, K. S., and P. J. O'Dwyer. 1995. Involvement of NF-κB in the induction of NAD(P)H:quinone oxidoreductase (DT-diaphorase) by hypoxia, oltipraz and mitomycin C. Biochem. Pharmacol. 49: 275-282.
38. Yao, K. S., and P. J. O'Dwyer. 2003. Role of the AP-1 element and redox factor-1 (Ref-1) in mediating transcriptional induction of DT-diaphorase gene expression by oltipraz: a target for chemoprevention. Biochem. Pharmacol. 66: 15-23.
39. Yao, J., N. Mackman, T. S. Edgington, and S. T. Fan. 1997. Lipopolysaccharide induction of the tumor necrosis factor-α promoter in human monocytic cells: regulation by Egr-1, c-Jun, and NF-κB transcription factors. J. Biol. Chem. 272: 17795-17801. (Pubitemid 27311220)
40. Iskander, K., J. Li, S. H. Han, B. Zheng, and A. K. Jaiswal. 2006. NQO1 and NQO2 regulation of humoral immunity and autoimmunity. J. Biol. Chem. 281: 30917-30924. (Pubitemid 44582146)
41. Chen, X. L., G. Dodd, S. Thomas, X. L. Zhang, M. A. Wasserman, B. H. Rovin, and C. Kunsch. 2006. Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression. Am. J. Physiol. 290: H1862-H1870.
42. Jeon, W.-K., and B.-C. Kim. 2007. Heme oxygenase-1 mediates the antiinflammatory effect of propyl gallate in LPS-stimulated macrophages. Biochem. Biophys. Res. Commun. July 25. epub ahead of print.
43. Lee, T. S., and L. Y. Chau. 2002. Heme oxygenase-1 mediates the antiinflammatory effect of interleukin-10 in mice. Nat. Med. 8: 240-246.
44. 2. J. Biol. Chem. 278: 19325-19330.
45. True, A. L., M. Olive, M. Boehm, H. San, R. J. Westrick, N. Raghavachari, X. Xu, E. G. Lynn, M. N. Sack, P. J. Munson, et al. 2007. Heme oxygenase-1 deficiency accelerates formation of arterial thrombosis through oxidative damage to the endothelium, which is rescued by inhaled carbon monoxide. Circ. Res. 101: 893-901.